Gender Disparities in Type 2 Diabetes Risk Linked to Adipose Tissue and Insulin Sensitivity
New research presented at the European Congress on Obesity (ECO) in Venice, Italy, and published in the International Journal of Obesity reveals potential reasons for the higher prevalence of type 2 diabetes (T2D) in men compared to women. The study explores the role of adipose tissue and insulin sensitivity in this gender disparity, suggesting that differences in adipose insulin resistance between men and women may contribute to the increased risk of T2D in men.
Study Shows SGLT2 Inhibitors May Lower Risk of Kidney Stones in Adults with Type 2 Diabetes
A recent study published in JAMA Internal Medicine found that adults with type 2 diabetes may benefit from lower risk of nephrolithiasis by initiating SGLT2 inhibitors. The research compared the effects of different type 2 diabetes medications on the risk of developing kidney stones and found that SGLT2 inhibitors outperformed other medications in reducing the risk of nephrolithiasis. This finding could have significant implications for the treatment and management of type 2 diabetes, as kidney stones can be a serious complication for individuals with the condition.
New Study Shows Ozempic and Semaglutide May Lower Risk of Severe Liver Diseases
A nationwide study in Sweden suggests that GLP1 agonists like Ozempic could lower the risk of cirrhosis and liver cancer in individuals with type 2 diabetes and chronic liver disease. This new finding provides a potential life-saving benefit of these medications, offering a new treatment option for preventing severe liver diseases.
SGLT2 Inhibitors May Lower Risk of Kidney Stones in Type 2 Diabetes Patients
Rates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidney stones, but some forms of treatment for this condition may also have the benefit…
Study Investigates Impact of Type 2 Diabetes and Genetic Susceptibility on COVID-19 Severity and Mortality
In a recent study published in Communications Biology, a team of scientists investigated how type 2 diabetes and genetic susceptibility to the disease impacted the severity of and mortality risk associated with coronavirus disease 2019 (COVID-19) using data from the…
Diabetes Drug Shows Promise in Protecting Against Colorectal Cancer
A recent analysis by researchers in the US suggests that a drug commonly used to treat type 2 diabetes could also be effective in protecting against colorectal cancer (CRC). The drug, known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), has…